These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 566185)

  • 41. Dopaminergic effects of lergotrile: possible involvement of a metabolite.
    McDevitt JT; Setler PE
    Neuropharmacology; 1980 Jun; 19(6):537-42. PubMed ID: 6105627
    [No Abstract]   [Full Text] [Related]  

  • 42. Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.
    Nausieda PA; Weiner WJ; Kanapa DJ; Klawans HL
    Neurology; 1978 Nov; 28(11):1183-8. PubMed ID: 568738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible role of dopamine in central effects of cocaine as measured by apomorphine gnawing test in mice.
    Dadkar NK; Dohadwalla AN; Bhattacharya BK
    Psychopharmacology (Berl); 1977 Apr; 52(2):115-7. PubMed ID: 407594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. L-DOPA reversal of hyperdopaminergic behaviour.
    Ezrin-Waters C; Seeman P
    Life Sci; 1978 Mar; 22(12):1027-32. PubMed ID: 565450
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of dopaminergic mechanisms in naloxone-induced inhibition of apomorphine-induced stereotyped behavior.
    Moon BH; Feigenbaum JJ; Carson PE; Klawans HL
    Eur J Pharmacol; 1980 Jan; 61(1):71-8. PubMed ID: 7188752
    [No Abstract]   [Full Text] [Related]  

  • 46. Modulation of dexamphetamine-induced compulsive gnawing--including the possible involvement of presynaptic alpha-adrenoreceptors.
    Thomas KV; Handley SL
    Psychopharmacology (Berl); 1978 Jan; 56(1):61-7. PubMed ID: 203967
    [No Abstract]   [Full Text] [Related]  

  • 47. Behavioral facilitation following chronic administration of N-n-propylnorapomorphine.
    Wilcox RE; Riffee WH; Chen PC; Hammett S; Smith RV
    Psychopharmacology (Berl); 1980; 72(1):113-5. PubMed ID: 6781003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour.
    Carter CJ; Pycock CJ
    Life Sci; 1978 Sep; 23(9):953-60. PubMed ID: 568208
    [No Abstract]   [Full Text] [Related]  

  • 49. Potentiation of apomorphine and D-amphetamine effects by naloxone.
    Adams PM; Beauchamp R; Alston C
    Life Sci; 1981 Feb; 28(6):629-34. PubMed ID: 7193793
    [No Abstract]   [Full Text] [Related]  

  • 50. Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats: A.M. Ernst. Psychopharmacologia (Berl.) 10, 316-323 (1967).
    Robbins TW; de Wied D
    Psychopharmacology (Berl); 1991; 103(3):285-6. PubMed ID: 2057533
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of unilateral carotid occlusion on apomorphine-induced turning in rats.
    Mears A; Barnett A
    Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):128-32. PubMed ID: 4477705
    [No Abstract]   [Full Text] [Related]  

  • 52. Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model.
    Marshall JF; Ungerstedt U
    Eur J Pharmacol; 1977 Feb; 41(4):361-7. PubMed ID: 557411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of carbon disulphide on the stereotypic effect of dopamine agonists.
    Magos L
    Eur J Pharmacol; 1976 Mar; 36(1):257-8. PubMed ID: 944133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
    Jaton AL; Loew DM; Vigouret JM
    Br J Pharmacol; 1978 Mar; 62(3):395P. PubMed ID: 565235
    [No Abstract]   [Full Text] [Related]  

  • 55. Extrapyramidal and mesolimbic involvement with the stereotypic activity of D- and L-amphetamine.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Feb; 25(2):121-9. PubMed ID: 4474081
    [No Abstract]   [Full Text] [Related]  

  • 56. Failure of apomorphine to induce dopamine receptor hypersensitivity.
    Flemenbaum A
    Psychopharmacology (Berl); 1979 Apr; 62(2):175-9. PubMed ID: 111281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.
    Baldessarini RJ; Kula NS; Walton KG
    Psychopharmacology (Berl); 1977 Jun; 53(1):45-53. PubMed ID: 407613
    [No Abstract]   [Full Text] [Related]  

  • 58. Modification of postsynaptic dopaminergic sensitivity by female sex hormones.
    Nausieda PA; Koller WC; Weiner WJ; Klawans HL
    Life Sci; 1979 Aug; 25(6):521-6. PubMed ID: 573836
    [No Abstract]   [Full Text] [Related]  

  • 59. GABA agonists dissociate striatal unit activity from drug-induced stereotyped behaviour.
    McKenzie GM; Hansen EL
    Neuropharmacology; 1980 Oct; 19(10):957-62. PubMed ID: 7191485
    [No Abstract]   [Full Text] [Related]  

  • 60. Sensitivity to apomorphine in the guinea pig as a function of age and body weight.
    Carlson KR; Almasi J
    Psychopharmacology (Berl); 1978 May; 57(3):279-82. PubMed ID: 97709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.